Pindolol

"Pindolol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)

Descriptor ID

D010869

MeSH Number(s)

D02.033.100.624.698.699

D02.033.100.624.748

D02.033.755.624.698.699

D02.033.755.624.748

D02.092.063.624.698.699

Concept/Terms

Pindolol

Visken

LB-46

Below are MeSH descriptors whose meaning is more general than "Pindolol".

Chemicals and Drugs [D]
Organic Chemicals [D02]
Alcohols [D02.033]
Amino Alcohols [D02.033.100]
Propanolamines [D02.033.100.624]
Pindolol [D02.033.100.624.748]
Propanols [D02.033.755]
Propanolamines [D02.033.755.624]
Pindolol [D02.033.755.624.748]
Amines [D02.092]
Amino Alcohols [D02.092.063]
Propanolamines [D02.092.063.624]
Phenoxypropanolamines [D02.092.063.624.698]
Pindolol [D02.092.063.624.698.699]

Below are MeSH descriptors whose meaning is more specific than "Pindolol".

Pindolol
Iodocyanopindolol

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Pindolol" by people in Harvard Catalyst Profiles by year, and whether "Pindolol" was a major or minor topic of these publication.

Bar chart showing 10 publications over 7 distinct years, with a maximum of 3 publications in 2001

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	1	1	2
1999	0	1	1
2000	0	1	1
2001	2	1	3
2002	0	1	1
2004	1	0	1
2005	0	1	1

Below are the most recent publications written about "Pindolol" by people in Profiles.

Analysis of brain adrenergic receptors in dopamine-beta-hydroxylase knockout mice. Brain Res. 2006 Sep 13; 1109(1):45-53.

View in: PubMed
Insomnia improvement during antidepressant treatment and CLOCK gene polymorphism. Am J Med Genet B Neuropsychiatr Genet. 2005 Aug 05; 137B(1):36-9.

View in: PubMed
Pindolol does not augment cortisol and prolactin responses to paroxetine in healthy subjects. Prog Neuropsychopharmacol Biol Psychiatry. 2004 May; 28(3):477-80.

View in: PubMed
Pindolol augmentation in depressed patients resistant to selective serotonin reuptake inhibitors: a double-blind, randomized, controlled trial. J Clin Psychiatry. 2004 Feb; 65(2):238-43.

View in: PubMed
Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity. Int J Neuropsychopharmacol. 2002 Mar; 5(1):27-35.

View in: PubMed
Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression. Biol Psychiatry. 2001 Sep 01; 50(5):323-30.

View in: PubMed
Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity. Mol Psychiatry. 2001 Sep; 6(5):586-92.

View in: PubMed
Differential occupancy of somatodendritic and postsynaptic 5HT(1A) receptors by pindolol: a dose-occupancy study with [11C]WAY 100635 and positron emission tomography in humans. Neuropsychopharmacology. 2001 Mar; 24(3):209-29.

View in: PubMed
New approaches to the treatment of refractory depression. J Clin Psychiatry. 2000; 61 Suppl 1:26-32.

View in: PubMed
Both 5-HT1B and 5-HT1F receptors modulate c-fos expression within rat trigeminal nucleus caudalis. Eur J Pharmacol. 1999 Mar 26; 369(3):271-7.

View in: PubMed

Related Networks

People

Explore

Similar Concepts

Top Journals

J Pharmacol Exp Ther
J Biol Chem
J Clin Psychiatry
Endocrinology
Life Sci
Eur J Biochem
EMBO J
Biol Psychiatry
Am J Cardiol
Am Heart J